These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

474 related items for PubMed ID: 8996758

  • 1. Donor-specific HLA antibodies after transplantation are associated with deterioration in cardiac function.
    Leech SH, Mather PJ, Eisen HJ, Pina IL, Margulies KB, Bove AA, Jeevanandam V.
    Clin Transplant; 1996 Dec; 10(6 Pt 2):639-45. PubMed ID: 8996758
    [Abstract] [Full Text] [Related]

  • 2. Utility of posttransplantation panel-reactive antibody measurements for the prediction of rejection frequency and survival of heart transplant recipients.
    George JF, Kirklin JK, Shroyer TW, Naftel DC, Bourge RC, McGiffin DC, White-Williams C, Noreuil T.
    J Heart Lung Transplant; 1995 Dec; 14(5):856-64. PubMed ID: 8800720
    [Abstract] [Full Text] [Related]

  • 3. Donor-specific HLA alloantibodies: long-term impact on cardiac allograft vasculopathy and mortality after heart transplant.
    Kaczmarek I, Deutsch MA, Kauke T, Beiras-Fernandez A, Schmoeckel M, Vicol C, Sodian R, Reichart B, Spannagl M, Ueberfuhr P.
    Exp Clin Transplant; 2008 Sep; 6(3):229-35. PubMed ID: 18954302
    [Abstract] [Full Text] [Related]

  • 4. Donor-specific HLA antibodies in paediatric cardiac transplant recipients are associated with poor graft survival.
    Irving C, Carter V, Parry G, Hasan A, Kirk R.
    Pediatr Transplant; 2011 Mar; 15(2):193-7. PubMed ID: 21199210
    [Abstract] [Full Text] [Related]

  • 5. Hepatocyte growth factor and antibodies to HLA and MICA antigens in heart transplant recipients.
    Pavlova YA, Malek I, Honsova E, Netuka I, Sochman J, Lodererova A, Kolesar L, Striz I, Skibova J, Slavcev A.
    Tissue Antigens; 2010 Nov; 76(5):380-6. PubMed ID: 20604893
    [Abstract] [Full Text] [Related]

  • 6. Utility of post-transplant anti-HLA antibody measurements in pediatric cardiac transplant recipients.
    Xydas S, Yang JK, Burke EM, Chen JM, Addonizio LJ, Mital SR, Itescu S, Hsu DT, Lamour JM.
    J Heart Lung Transplant; 2005 Sep; 24(9):1289-96. PubMed ID: 16143247
    [Abstract] [Full Text] [Related]

  • 7. Alloantibodies in heart transplantation.
    Ho EK, Vlad G, Colovai AI, Vasilescu ER, Schwartz J, Sondermeijer H, Burke E, Marboe CC, Itescu S, Suciu-Foca N, Mancini D.
    Hum Immunol; 2009 Oct; 70(10):825-9. PubMed ID: 19555730
    [Abstract] [Full Text] [Related]

  • 8. Heart transplantation across antibodies against human leukocyte antigen and ABO-post-transplant follow-up of donor reactive antibodies.
    Bućin D, Johansson S, Lindberg LO.
    Xenotransplantation; 2006 Mar; 13(2):101-4. PubMed ID: 16623800
    [Abstract] [Full Text] [Related]

  • 9. Clinical and anti-HLA antibody profile of nine renal transplant recipients with failed grafts: donor-specific and non-donor-specific antibody development.
    Rebellato LM, Ozawa M, Verbanac KM, Catrou P, Haisch CE, Terasaki PI.
    Clin Transpl; 2006 Mar; ():241-53. PubMed ID: 18365382
    [Abstract] [Full Text] [Related]

  • 10. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL, Jin XB, Li XT, Wang HW, Lü JJ.
    Chin Med J (Engl); 2009 Feb 20; 122(4):420-6. PubMed ID: 19302748
    [Abstract] [Full Text] [Related]

  • 11. Interleukin-2 receptor blockade in cardiac transplantation: influence of HLA-DR locus incompatibility on treatment efficacy.
    Lietz K, John R, Beniaminovitz A, Burke EM, Suciu-Foca N, Mancini DM, Edwards NM, Itescu S.
    Transplantation; 2003 Mar 27; 75(6):781-7. PubMed ID: 12660501
    [Abstract] [Full Text] [Related]

  • 12. Post transplant development of MICA and anti-HLA antibodies is associated with acute rejection episodes and renal allograft loss.
    Panigrahi A, Gupta N, Siddiqui JA, Margoob A, Bhowmik D, Guleria S, Mehra NK.
    Hum Immunol; 2007 May 27; 68(5):362-7. PubMed ID: 17462503
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Aortic valve allograft structural deterioration is associated with a subset of antibodies to human leukocyte antigens.
    Dignan R, O'Brien M, Hogan P, Thornton A, Fowler K, Byrne D, Stephens F, Harrocks S.
    J Heart Valve Dis; 2003 May 27; 12(3):382-90; discussion 390-1. PubMed ID: 12803340
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Sensitisation and post-transplant course after the implantation of ventricular assist device.
    Malickaite R, Rucinskas K, Staneviciene A, Miniauskas S, Maneikiene V, Zuoziene G, Sirvydis V.
    Interact Cardiovasc Thorac Surg; 2009 Mar 27; 8(3):339-42; discussion 342-3. PubMed ID: 19098066
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.